Teladoc, Microsoft partner to expand telehealth

Teladoc, a provider of virtual care delivery services, has announced an expanded partnership with Microsoft to advance telehealth capabilities.

As telehealth services become increasingly popular in conventional care, developers are looking to expand capabilities to meet demand of patients and clinicians. By combining Teledoc’s platform with the Microsoft Azure cloud platform, hospitals and healthcare systems across America hope to improve access to virtual care to better meet the needs of patients.

“Teladoc is committed to providing a superior telehealth solution to our clients,” said Alan Roga, MD, president, hospital and health systems at Teladoc. “Whether it’s the Microsoft Azure platform or any of a number of other Microsoft applications that will support the success of our clients’ telehealth goals, our focus remains on providing a secure, flexible and reliable platform for all of our health system clients.”

After doubling market growth in hospitals and healthcare systems in the past year, Teledoc aims to leverage Azure to deliver telehealth to more than 250 hospitals and healthcare systems. This improved reach of telehealth could increase patient base and improve care and workflow. With Microsoft, Teledoc is able to leverage all HITRUST-certified Azure cloud services to provide highly scalable, redundant and secure applications to clients.

“Consumer telehealth is now becoming central to hospital and health system strategy,” said Neil Jordan, general manager of Worldwide Health at Microsoft. “In combination with the security and global scale of Microsoft Azure, we can jointly take Teladoc’s solution to market to successfully expand use cases in current clients and reach many more new ones, helping Teladoc’s provider customers improve the healthcare experience.”

""
Cara Livernois, News Writer

Cara joined TriMed Media in 2016 and is currently a Senior Writer for Clinical Innovation & Technology. Originating from Detroit, Michigan, she holds a Bachelors in Health Communications from Grand Valley State University.

Around the web

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met. 

When regulating AI-equipped medical devices, the FDA might take a page from the Department of Transportation’s playbook for overseeing AI-equipped vehicles. These run the gamut from assisting human drivers to fully taking the wheel. 

Kit Crancer, RBMA board member, speaks with Radiology Business about key legislative developments on the Hill that will affect the specialty.